Epilepsy Device Market Research Report—Global Forecast till 2027

てんかんデバイス市場:製品タイプ(従来のデバイス、ウェアラブルデバイス、埋め込み型デバイス、ダイエット)、テクノロジー(迷走神経刺激、深部脳刺激、加速度測定、応答性神経刺激)、発作検出および予測デバイス(脳波、頭蓋内脳波)による情報、表面筋電図、心電図、ビデオ検出システム、皮膚電気活動、移植アドバイザリーシステム)、エンドユーザー(病院および診療所、神経センター、在宅ケア施設)、および地域別(南北アメリカ、ヨーロッパ、アジア太平洋、中東、アフリカ)—2027年までの予測

ID: MRFR/HC/8947-CR | November 2021 | Region: Global | 169 Pages         

TABLE OF CONTENTS

1 EXECUTIVE SUMMARY

2 MARKET INTRODUCTION

2.1 SCOPE OF THE STUDY

2.2 RESEARCH OBJECTIVE

2.3 LIST OF ASSUMPTIONS

3 RESEARCH METHODOLOGY

3.1 OVERVIEW

3.2 DATA MINING

3.3 SECONDARY RESEARCH

3.4 PRIMARY RESEARCH

3.4.1 PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS

3.4.2 BREAKDOWN OF PRIMARY RESPONDENTS

3.5 FORECASTING TECHNIQUES

3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION

3.6.1 BOTTOM-UP APPROACH

3.6.2 TOP-DOWN APPROACH

3.7 DATA TRIANGULATION

3.8 VALIDATION

4 MARKET DYNAMICS

4.1 OVERVIEW

4.2 DRIVERS

4.2.1 GROWING PREVALENCE OF EPILEPSY AMONGST THE GERIATRIC POPULATION

4.2.2 INCREASING CASES OF BRAIN INJURIES DUE TO ROAD ACCIDENTS

4.2.3 RISING NEUROLOGICAL DISORDERS

4.3 RESTRAINTS

4.3.1 LACK OF PUBLIC AWARENESS AND AVAILABILITY OF EPILEPSY DEVICES IN DEVELOPING NATIONS

4.4 OPPORTUNITIES

4.4.1 EMERGING MARKETS FOR EPILEPSY DEVICES

5 MARKET FACTOR ANALYSIS

5.1 VALUE CHAIN ANALYSIS

5.1.1 R&D

5.1.2 MANUFACTURING

5.1.3 DISTRIBUTION AND SALES

5.1.4 POST-SALES MONITORING

5.2 PORTER'S FIVE FORCES MODEL

5.2.1 BARGAINING POWER OF SUPPLIERS

5.2.2 BARGAINING POWER OF BUYERS

5.2.3 THREAT OF NEW ENTRANTS

5.2.4 THREAT OF SUBSTITUTES

5.2.5 INTENSITY OF RIVALRY

5.3 IMPACT OF COVID-19 ON THE EPILEPSY DEVICES MARKET

5.3.1 IMPACT ON DEMAND

5.3.2 IMPACT ON EPILEPSY PATIENTS

5.3.3 IMPACT ON GDP

5.3.4 IMPACT ON SUPPLY CHAIN

5.4 ESTIMATION OF ELIGIBLE PATIENTS AND SURGICAL CASE LOADS/TREATMENT IN EPILEPSY

6 GLOBAL EPILEPESY DEVICES MARKET, BY PRODUCT TYPE

6.1 OVERVIEW

6.2 CONVENTIONAL DEVICES

6.3 WERABLE DEVICES

6.3.1 WATCHES

6.3.2 BRACELETS

6.3.3 BRACELETS

6.3.4 MATTRESS DEVICES

6.3.5 ANTI-SUFFOCATION PILLOWS

6.3.6 OTHERS

6.4 IMPLANTABLE DEVICES

6.5 DIET

6.5.1 KETOGENIC DIET

6.5.2 OTHERS

7 GLOBAL EPILEPSY DEVICES MARKET, BY TECHNOLOGY

7.1 OVERVIEW

7.2 VAGUS NERVE STIMULATION

7.3 DEEP BRAIN STIMULATION

7.3.1 MOVEMENT DISORDERS

7.3.2 EPILEPSY

7.4 ACCELEROMETERY

7.5 RESPONSIVE NEUROSTIMULATION

8 GLOBAL EPILEPSY DEVICES MARKET, BY SEZIURE DETECTION AND PREDICTION DEVICES

8.1 OVERVIEW

8.2 ELECTROENCEPHALOGRAM

8.3 INTRACRANIAL EEG

8.4 SURFACE ELECTROMYOGRAPHY

8.5 ELECTROCARDIOGRAPHY

8.6 VIDEO DETECTION SYSTEMS

8.7 ELECTRODERMAL ACTIVITY

8.8 IMPLANTED ADVISORY SYSTEMS

8.9 OTHERS

9 GLOBAL EPILEPSY DEVICES MARKET BY END USER

9.1 OVERVIEW

9.2 HOSPITALS AND CLINICS

9.3 NEUROLOGY CENTERS

9.4 HOME CARE SETTINGS

9.5 OTHERS

10 GLOBAL EPILEPSY DEVICES MARKET, BY REGION

10.1 OVERVIEW

10.2 AMERICAS

10.2.1 NORTH AMERICA

10.2.1.1 US

10.2.1.2 CANADA

10.2.2 LATIN AMERICA

10.3 EUROPE

10.3.1 WESTERN EUROPE

10.3.1.1 GERMANY

10.3.1.2 FRANCE

10.3.1.3 UK

10.3.1.4 ITALY

10.3.1.5 SPAIN

10.3.1.6 REST OF WESTERN EUROPE

10.3.2 EASTERN EUROPE

10.4 ASIA PACIFIC

10.4.1 CHINA

10.4.2 INDIA

10.4.3 JAPAN

10.4.4 SOUTH KOREA

10.4.5 AUSTRALIA

10.4.6 REST OF ASIA PACIFIC

10.5 MIDDLE EAST & AFRICA

10.5.1 MIDDLE EAST

10.5.2 AFRICA

11 COMPETITIVE LANDSCAPE

11.1 OVERVIEW

11.2 COMPETITIVE BENCHMARKING

11.3 MAJOR GROWTH STRATEGY IN THE GLOBAL EPILEPSY DEVICES MARKET

11.4 THE LEADING PLAYER IN TERMS OF NUMBER OF DEVELOPMENTS IN THE GLOBAL EPILEPSY DEVICES MARKET

11.5 KEY DEVELOPMENT ANALYSIS

11.6 KEY DEVELOPMENTS & GROWTH STRATEGIES

11.6.1 PRODUCT LAUNCH/PRODUCT APPROVAL

11.6.2 PARTNERSHIP/AGREEMENT

11.6.3 COLLABORATION

11.7 MAJOR PLAYERS FINANCIAL MATRIX

11.7.1 SALES (USD MILLION), 2020

11.7.2 R&D EXPENDITURE (USD MILLION), 2020

12 COMPANY PROFILES

12.1 LIVANOVA PLC

12.1.1 COMPANY OVERVIEW

12.1.2 FINANCIAL OVERVIEW

12.1.3 PRODUCTS/SERVICES OFFERED

12.1.4 KEY DEVELOPMENTS

12.1.5 SWOT ANALYSIS

12.1.6 KEY STRATEGIES

12.2 MEDTRONIC PLC

12.2.1 COMPANY OVERVIEW

12.2.2 FINANCIAL OVERVIEW

12.2.3 PRODUCTS/SERVICES OFFERED

12.2.4 KEY DEVELOPMENTS

12.2.5 SWOT ANALYSIS

12.2.6 KEY STRATEGIES

12.3 MEDPAGE LTD.

12.3.1 COMPANY OVERVIEW

12.3.2 FINANCIAL OVERVIEW

12.3.3 PRODUCTS/SERVICES OFFERED

12.3.4 KEY DEVELOPMENTS

12.3.5 SWOT ANALYSIS

12.3.6 KEY STRATEGIES

12.4 KONINKLIJKE PHILIPS NV

12.4.1 COMPANY OVERVIEW

12.4.2 FINANCIAL OVERVIEW

12.4.3 PRODUCTS/SERVICES OFFERED

12.4.4 KEY DEVELOPMENTS

12.4.5 SWOT ANALYSIS

12.4.6 KEY STRATEGIES

12.5 COMPUMEDICS LIMITED

12.5.1 COMPANY OVERVIEW

12.5.2 FINANCIAL OVERVIEW

12.5.3 PRODUCTS/SERVICES OFFERED

12.5.4 KEY DEVELOPMENTS

12.5.5 SWOT ANALYSIS

12.5.6 KEY STRATEGIES

12.6 NATUS MEDICAL INCORPORATED

12.6.1 COMPANY OVERVIEW

12.6.2 FINANCIAL OVERVIEW

12.6.3 PRODUCTS/SERVICES OFFERED

12.6.4 KEY DEVELOPMENTS

12.6.5 SWOT ANALYSIS

12.6.6 KEY STRATEGIES

12.7 NIHON KOHDEN CORPORATION

12.7.1 COMPANY OVERVIEW

12.7.2 FINANCIAL OVERVIEW

12.7.3 PRODUCTS/SERVICES OFFERED

12.7.4 KEY DEVELOPMENTS

12.7.5 SWOT ANALYSIS

12.7.6 KEY STRATEGIES

12.8 MC10

12.8.1 COMPANY OVERVIEW

12.8.2 FINANCIAL OVERVIEW

12.8.3 PRODUCTS/SERVICES OFFERED

12.8.4 KEY DEVELOPMENTS

12.8.5 SWOT ANALYSIS

12.8.6 KEY STRATEGIES

12.9 EMPATICA INC.

12.9.1 COMPANY OVERVIEW

12.9.2 FINANCIAL OVERVIEW

12.9.3 PRODUCTS/SERVICES OFFERED

12.9.4 KEY DEVELOPMENTS

12.9.5 SWOT ANALYSIS

12.9.6 KEY STRATEGIES

12.10 NEUROPACE, INC.

12.10.1 COMPANY OVERVIEW

12.10.2 FINANCIAL OVERVIEW

12.10.3 PRODUCTS/SERVICES OFFERED

12.10.4 KEY DEVELOPMENTS

12.10.5 SWOT ANALYSIS

12.10.6 KEY STRATEGIES

12.11 BOSTON SCIENTIFIC CORPORATION

12.11.1 COMPANY OVERVIEW

12.11.2 FINANCIAL OVERVIEW

12.11.3 PRODUCTS/SERVICES OFFERED

12.11.4 KEY DEVELOPMENTS

12.11.5 SWOT ANALYSIS

12.11.6 KEY STRATEGIES

13 APPENDIX

13.1 REFERENCES

13.2 RELATED REPORTS


LIST OF TABLES

TABLE 1 LIST OF ASSUMPTIONS

TABLE 2 GLOBAL: EPILEPSY DEVICES MARKET, BY PRODUCT TYPE, 2018–2027 (USD MILLION)

TABLE 3 GLOBAL: EPILEPSY DEVICES MARKET, FOR CONVENTIONAL DEVICES, BY REGION, 2018–2027 (USD MILLION)

TABLE 4 GLOBAL: EPILEPSY DEVICES MARKET, FOR WEARABLE DEVICES, BY REGION, 2018–2027 (USD MILLION)

TABLE 5 GLOBAL: EPILEPSY DEVICES MARKET, FOR WATCHES, BY REGION, 2018–2027 (USD MILLION)

TABLE 6 GLOBAL: EPILEPSY DEVICES MARKET, FOR BRACELETS, BY REGION, 2018–2027 (USD MILLION)

TABLE 7 GLOBAL: EPILEPSY DEVICES MARKET, FOR BRACELETS, BY REGION, 2018–2027 (USD MILLION)

TABLE 8 GLOBAL: EPILEPSY DEVICES MARKET, FOR MATTRESS DEVICES, BY REGION, 2018–2027 (USD MILLION)

TABLE 9 GLOBAL: EPILEPSY DEVICES MARKET, FOR ANTI-SUFFOCATION PILLOWS, BY REGION, 2018–2027 (USD MILLION)

TABLE 10 GLOBAL: EPILEPSY DEVICES MARKET, FOR OTHERS, BY REGION, 2018–2027 (USD MILLION)

TABLE 11 GLOBAL: EPILEPSY DEVICES MARKET, FOR IMPLANTABLE DEVICES, BY REGION, 2018–2027 (USD MILLION)

TABLE 12 GLOBAL: EPILEPSY DEVICES MARKET, FOR DIET, BY REGION, 2018–2027 (USD MILLION)

TABLE 13 GLOBAL: EPILEPSY DEVICES MARKET, FOR KETOGENIC DIET, BY REGION, 2018–2027 (USD MILLION)

TABLE 14 GLOBAL: EPILEPSY DEVICES MARKET, FOR OTHERS, BY REGION, 2018–2027 (USD MILLION)

TABLE 15 GLOBAL: EPILEPSY DEVICES MARKET, BY TECHNOLOGY, 2018–2027 (USD MILLION)

TABLE 16 GLOBAL: EPILEPSY DEVICES MARKET, FOR VAGUS NERVE STIMULATION, BY REGION, 2018–2027 (USD MILLION)

TABLE 17 GLOBAL: EPILEPSY DEVICES MARKET, FOR DEEP BRAIN STIMULATION, BY REGION, 2018–2027 (USD MILLION)

TABLE 18 GLOBAL: EPILEPSY DEVICES MARKET, FOR MOVEMENT DISORDERS, BY REGION, 2018–2027 (USD MILLION)

TABLE 19 GLOBAL: EPILEPSY DEVICES MARKET, FOR EPILEPSY, BY REGION, 2018–2027 (USD MILLION)

TABLE 20 GLOBAL: EPILEPSY DEVICES MARKET, FOR ACCELEROMETERY, BY REGION, 2018–2027 (USD MILLION)

TABLE 21 GLOBAL: EPILEPSY DEVICES MARKET, FOR RESPONSIVE NEUROSTIMULATION, BY REGION, 2018–2027 (USD MILLION)

TABLE 22 GLOBAL: EPILEPSY DEVICES MARKET, BY SEIZURE DETECTION AND PREDICTION DEVICES, 2018–2027 (USD MILLION)

TABLE 23 GLOBAL: EPILEPSY DEVICES MARKET, FOR ELECTROENCEPHALOGRAM, BY REGION, 2018–2027 (USD MILLION)

TABLE 24 GLOBAL: EPILEPSY DEVICES MARKET, FOR INTRACRANIAL EEG, BY REGION, 2018–2027 (USD MILLION)

TABLE 25 GLOBAL: EPILEPSY DEVICES MARKET, FOR SURFACE ELECTROMYOGRAPHY, BY REGION, 2018–2027 (USD MILLION)

TABLE 26 GLOBAL: EPILEPSY DEVICES MARKET, FOR ELECTROCARDIOGRAPHY, BY REGION, 2018–2027 (USD MILLION)

TABLE 27 GLOBAL: EPILEPSY DEVICES MARKET, FOR VIDEO DETECTION SYSTEMS, BY REGION, 2018–2027 (USD MILLION)

TABLE 28 GLOBAL: EPILEPSY DEVICES MARKET, FOR ELECTRODERMAL ACTIVITY, BY REGION, 2018–2027 (USD MILLION)

TABLE 29 GLOBAL: EPILEPSY DEVICES MARKET, FOR IMPLANTED ADVISORY SYSTEMS, BY REGION, 2018–2027 (USD MILLION)

TABLE 30 GLOBAL: EPILEPSY DEVICES MARKET, FOR OTHERS, BY REGION, 2018–2027 (USD MILLION)

TABLE 31 GLOBAL: EPILEPSY DEVICES MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 32 GLOBAL: EPILEPSY DEVICES MARKET, BY HOSPITALS & CLINICS, 2018–2027 (USD MILLION)

TABLE 33 GLOBAL: EPILEPSY DEVICES MARKET, BY NEUROLOGY CENTERS, 2018–2027 (USD MILLION)

TABLE 34 GLOBAL: EPILEPSY DEVICES MARKET, BY HOME CARE SETTINGS, 2018–2027 (USD MILLION)

TABLE 35 GLOBAL: EPILEPSY DEVICES MARKET, BY OTHERS, 2018–2027 (USD MILLION)

TABLE 36 GLOBAL: EPILEPSY DEVICES MARKET, BY REGION, 2018–2027 (USD MILLION)

TABLE 37 AMERICAS: EPILEPSY DEVICES MARKET, BY REGION, 2018–2027 (USD MILLION)

TABLE 38 AMERICAS: EPILEPSY DEVICES MARKET, BY PRODUCT TYPE, 2018–2027 (USD MILLION)

TABLE 39 AMERICAS: EPILEPSY DEVICES MARKET FOR WEARABLE DEVICES, BY TYPE, 2018–2027 (USD MILLION)

TABLE 40 AMERICAS: EPILEPSY DEVICES MARKET FOR DIET, BY TYPE, 2018–2027 (USD MILLION)

TABLE 41 AMERICAS: EPILEPSY DEVICES MARKET, BY TECHNOLOGY, 2018–2027 (USD MILLION)

TABLE 42 AMERICAS: EPILEPSY DEVICES MARKET FOR DEEP BRAIN STIMULATION, BY TYPE 2018–2027 (USD MILLION)

TABLE 43 AMERICAS: EPILEPSY DEVICES MARKET FOR SEZIURE DETECTION AND PREDICTION DEVICES, 2018–2027 (USD MILLION)

TABLE 44 AMERICAS: EPILEPSY DEVICES MARKET, BY END USER, 2018–2027 (USD MILLION)

TABLE 45 NORTH AMERICA: EPILEPSY DEVICES MARKET, BY PRODUCT TYPE, 2018–2027 (USD MILLION)

TABLE 46 NORTH AMERICA: EPILEPSY DEVICES MARKET FOR WEARABLE DEVICES, BY TYPE, 2018–2027 (USD MILLION)

TABLE 47 NORTH AMERICA: EPILEPSY DEVICES MARKET FOR DIET, BY TYPE, 2018–2027 (USD MILLION)

TABLE 48 NORTH AMERICA: EPILEPSY DEVICES MARKET, BY TECHNOLOGY, 2018–2027 (USD MILLION)

TABLE 49 NORTH AMERICA: EPILEPSY DEVICES MARKET FOR DEEP BRAIN STIMULATION, BY TYPE 2018–2027 (USD MILLION)

TABLE 50 NORTH AMERICA: EPILEPSY DEVICES MARKET, BY SEZIURE DETECTION AND PREDICTION DEVICES, 2018–2027 (USD MILLION)

TABLE 51 NORTH AMERICA: EPILEPSY DEVICES MARKET, BY END USER, 2018–2027 (USD MILLION)

TABLE 52 US: EPILEPSY DEVICES MARKET, BY PRODUCT TYPE, 2018–2027 (USD MILLION)

TABLE 53 US: EPILEPSY DEVICES MARKET FOR WEARABLE DEVICES, BY TYPE, 2018–2027 (USD MILLION)

TABLE 54 US: EPILEPSY DEVICES MARKET FOR DIET, BY TYPE, 2018–2027 (USD MILLION)

TABLE 55 US: EPILEPSY DEVICES MARKET, BY TECHNOLOGY, 2018–2027 (USD MILLION)

TABLE 56 US: EPILEPSY DEVICES MARKET FOR DEEP BRAIN STIMULATION, BY TYPE, 2018–2027 (USD MILLION)

TABLE 57 US: EPILEPSY DEVICES MARKET, BY SEZIURE DETECTION AND PREDICTION DEVICES, 2018–2027 (USD MILLION)

TABLE 58 US: EPILEPSY DEVICES MARKET, BY END USER, 2018–2027 (USD MILLION)

TABLE 59 CANADA: EPILEPSY DEVICES MARKET, BY PRODUCT TYPE, 2018–2027 (USD MILLION)

TABLE 60 CANADA: EPILEPSY DEVICES MARKET FOR WEARABLE DEVICES, BY TYPE, 2018–2027 (USD MILLION)

TABLE 61 CANADA: EPILEPSY DEVICES MARKET FOR DIET, BY TYPE, 2018–2027 (USD MILLION)

TABLE 62 CANADA: EPILEPSY DEVICES MARKET, BY TECHNOLOGY, 2018–2027 (USD MILLION)

TABLE 63 CANADA: EPILEPSY DEVICES MARKET FOR DEEP BRAIN STIMULATION, BY TYPE 2018–2027 (USD MILLION)

TABLE 64 CANADA: EPILEPSY DEVICES MARKET, BY SEZIURE DETECTION AND PREDICTION DEVICES, 2018–2027 (USD MILLION)

TABLE 65 CANADA: EPILEPSY DEVICES MARKET, BY END USER, 2018–2027 (USD MILLION)

TABLE 66 LATIN AMERICA: EPILEPSY DEVICES MARKET, BY PRODUCT TYPE, 2018–2027 (USD MILLION)

TABLE 67 LATIN AMERICA: EPILEPSY DEVICES MARKET FOR WEARABLE DEVICES, BY TYPE, 2018–2027 (USD MILLION)

TABLE 68 LATIN AMERICA: EPILEPSY DEVICES MARKET FOR DIET, BY TYPE, 2018–2027 (USD MILLION)

TABLE 69 LATIN AMERICA: EPILEPSY DEVICES MARKET, BY TECHNOLOGY, 2018–2027 (USD MILLION)

TABLE 70 LATIN AMERICA: EPILEPSY DEVICES MARKET FOR DEEP BRAIN STIMULATION, BY TYPE 2018–2027 (USD MILLION)

TABLE 71 LATIN AMERICA: EPILEPSY DEVICES MARKET, BY SEZIURE DETECTION AND PREDICTION DEVICES, 2018–2027 (USD MILLION)

TABLE 72 LATIN AMERICA: EPILEPSY DEVICES MARKET, BY END USER, 2018–2027 (USD MILLION)

TABLE 73 EUROPE: EPILEPSY DEVICES MARKET, BY REGION, 2018–2027 (USD MILLION)

TABLE 74 EUROPE: EPILEPSY DEVICES MARKET, BY PRODUCT TYPE, 2018–2027 (USD MILLION)

TABLE 75 EUROPE: EPILEPSY DEVICES MARKET FOR WEARABLE DEVICES, BY TYPE, 2018–2027 (USD MILLION)

TABLE 76 EUROPE: EPILEPSY DEVICES MARKET FOR DIET, BY TYPE, 2018–2027 (USD MILLION)

TABLE 77 EUROPE: EPILEPSY DEVICES MARKET, BY TECHNOLOGY, 2018–2027 (USD MILLION)

TABLE 78 EUROPE: EPILEPSY DEVICES MARKET FOR DEEP BRAIN STIMULATION, BY TYPE 2018–2027 (USD MILLION)

TABLE 79 EUROPE: EPILEPSY DEVICES MARKET, BY SEZIURE DETECTION AND PREDICTION DEVICES, 2018–2027 (USD MILLION)

TABLE 80 EUROPE: EPILEPSY DEVICES MARKET, BY END USER, 2018–2027 (USD MILLION)

TABLE 81 EUROPE: EPILEPSY DEVICES MARKET, BY COUNTRY, 2018–2027 (USD MILLION)

TABLE 82 WESTERN EUROPE: EPILEPSY DEVICES MARKET, BY PRODUCT TYPE, 2018–2027 (USD MILLION)

TABLE 83 WESTERN EUROPE: EPILEPSY DEVICES MARKET FOR WEARABLE DEVICES, BY TYPE, 2018–2027 (USD MILLION)

TABLE 84 WESTERN EUROPE: EPILEPSY DEVICES MARKET FOR DIET, BY TYPE, 2018–2027 (USD MILLION)

TABLE 85 WESTERN EUROPE: EPILEPSY DEVICES MARKET, BY TECHNOLOGY, 2018–2027 (USD MILLION)

TABLE 86 WESTERN EUROPE: EPILEPSY DEVICES MARKET FOR DEEP BRAIN STIMULATION, BY TECHNOLOGY 2018–2027 (USD MILLION)

TABLE 87 WESTERN EUROPE: EPILEPSY DEVICES MARKET, BY SEZIURE DETECTION AND PREDICTION DEVICES, 2018–2027 (USD MILLION)

TABLE 88 WESTERN EUROPE: EPILEPSY DEVICES MARKET, BY END USER, 2018–2027 (USD MILLION)

TABLE 89 GERMANY: EPILEPSY DEVICES MARKET, BY PRODUCT TYPE, 2018–2027 (USD MILLION)

TABLE 90 GERMANY: EPILEPSY DEVICES MARKET FOR WEARABLE DEVICES, BY PRODUCT TYPE, 2018–2027 (USD MILLION)

TABLE 91 GERMANY: EPILEPSY DEVICES MARKET FOR DIET, BY TYPE, 2018–2027 (USD MILLION)

TABLE 92 GERMANY: EPILEPSY DEVICES MARKET, BY TECHNOLOGY, 2018–2027 (USD MILLION)

TABLE 93 GERMANY: EPILEPSY DEVICES MARKET FOR DEEP BRAIN STIMULATION, BY TYPE 2018–2027 (USD MILLION)

TABLE 94 GERMANY: EPILEPSY DEVICES MARKET, BY SEZIURE DETECTION AND PREDICTION DEVICES, 2018–2027 (USD MILLION)

TABLE 95 GERMANY: EPILEPSY DEVICES MARKET, BY END USER, 2018–2027 (USD MILLION)

TABLE 96 FRANCE: EPILEPSY DEVICES MARKET, BY PRODUCT TYPE, 2018–2027 (USD MILLION)

TABLE 97 FRANCE: EPILEPSY DEVICES MARKET FOR WEARABLE DEVICES, BY PRODUCT TYPE, 2018–2027 (USD MILLION)

TABLE 98 FRANCE: EPILEPSY DEVICES MARKET FOR DIET, BY TYPE, 2018–2027 (USD MILLION)

TABLE 99 FRANCE: EPILEPSY DEVICES MARKET, BY TECHNOLOGY, 2018–2027 (USD MILLION)

TABLE 100 FRANCE: EPILEPSY DEVICES MARKET FOR DEEP BRAIN STIMULATION, BY TYPE 2018–2027 (USD MILLION)

TABLE 101 FRANCE: EPILEPSY DEVICES MARKET, BY SEZIURE DETECTION AND PREDICTION DEVICES, 2018–2027 (USD MILLION)

TABLE 102 FRANCE: EPILEPSY DEVICES MARKET, BY END USER, 2018–2027 (USD MILLION)

TABLE 103 UK: EPILEPSY DEVICES MARKET, BY PRODUCT TYPE, 2018–2027 (USD MILLION)

TABLE 104 UK: EPILEPSY DEVICES MARKET FOR WEARABLE DEVICES, BY TYPE, 2018–2027 (USD MILLION)

TABLE 105 UK: EPILEPSY DEVICES MARKET FOR DIET, BY PRODUCT TYPE, 2018–2027 (USD MILLION)

TABLE 106 UK: EPILEPSY DEVICES MARKET, BY TECHNOLOGY, 2018–2027 (USD MILLION)

TABLE 107 UK: EPILEPSY DEVICES MARKET FOR DEEP BRAIN STIMULATION, BY TYPE 2018–2027 (USD MILLION)

TABLE 108 UK: EPILEPSY DEVICES MARKET, BY SEZIURE DETECTION AND PREDICTION DEVICES, 2018–2027 (USD MILLION)

TABLE 109 UK: EPILEPSY DEVICES MARKET, BY END USER, 2018–2027 (USD MILLION)

TABLE 110 ITALY: EPILEPSY DEVICES MARKET, BY PRODUCT TYPE, 2018–2027 (USD MILLION)

TABLE 111 ITALY: EPILEPSY DEVICES MARKET FOR WEARABLE DEVICES, BY TYPE, 2018–2027 (USD MILLION)

TABLE 112 ITALY: EPILEPSY DEVICES MARKET FOR DIET, BY TYPE, 2018–2027 (USD MILLION)

TABLE 113 ITALY: EPILEPSY DEVICES MARKET, BY TECHNOLOGY, 2018–2027 (USD MILLION)

TABLE 114 ITALY: EPILEPSY DEVICES MARKET FOR DEEP BRAIN STIMULATION, BY TYPE 2018–2027 (USD MILLION)

TABLE 115 ITALY: EPILEPSY DEVICES MARKET, BY SEZIURE DETECTION AND PREDICTION DEVICES, 2018–2027 (USD MILLION)

TABLE 116 ITALY: EPILEPSY DEVICES MARKET, BY END USER, 2018–2027 (USD MILLION)

TABLE 117 SPAIN: EPILEPSY DEVICES MARKET, BY PRODUCT TYPE, 2018–2027 (USD MILLION)

TABLE 118 SPAIN: EPILEPSY DEVICES MARKET FOR WEARABLE DEVICES, BY TYPE, 2018–2027 (USD MILLION)

TABLE 119 SPAIN: EPILEPSY DEVICES MARKET FOR DIET, BY TYPE, 2018–2027 (USD MILLION)

TABLE 120 SPAIN: EPILEPSY DEVICES MARKET, BY TECHNOLOGY, 2018–2027 (USD MILLION)

TABLE 121 SPAIN: EPILEPSY DEVICES MARKET FOR DEEP BRAIN STIMULATION, BY TECHNOLOGY 2018–2027 (USD MILLION)

TABLE 122 SPAIN: EPILEPSY DEVICES MARKET, BY SEZIURE DETECTION AND PREDICTION DEVICES, 2018–2027 (USD MILLION)

TABLE 123 SPAIN: EPILEPSY DEVICES MARKET, BY END USER, 2018–2027 (USD MILLION)

TABLE 124 REST OF WESTERN EUROPE: EPILEPSY DEVICES MARKET, BY PRODUCT TYPE, 2018–2027 (USD MILLION)

TABLE 125 REST OF WESTERN EUROPE: EPILEPSY DEVICES MARKET FOR WEARABLE DEVICES, BY TYPE, 2018–2027 (USD MILLION)

TABLE 126 REST OF WESTERN EUROPE: EPILEPSY DEVICES MARKET FOR DIET, BY TYPE, 2018–2027 (USD MILLION)

TABLE 127 REST OF WESTERN EUROPE: EPILEPSY DEVICES MARKET, BY TECHNOLOGY, 2018–2027 (USD MILLION)

TABLE 128 REST OF WESTERN EUROPE: EPILEPSY DEVICES MARKET FOR DEEP BRAIN STIMULATION, BY TECHNOLOGY 2018–2027 (USD MILLION)

TABLE 129 REST OF WESTERN EUROPE: EPILEPSY DEVICES MARKET, BY SEZIURE DETECTION AND PREDICTION DEVICES, 2018–2027 (USD MILLION)

TABLE 130 REST OF WESTERN EUROPE: EPILEPSY DEVICES MARKET, BY END USER, 2018–2027 (USD MILLION)

TABLE 131 EASTERN EUROPE: EPILEPSY DEVICES MARKET, BY PRODUCT TYPE, 2018–2027 (USD MILLION)

TABLE 132 EASTERN EUROPE: EPILEPSY DEVICES MARKET FOR WEARABLE DEVICES, BY TYPE, 2018–2027 (USD MILLION)

TABLE 133 EASTERN EUROPE: EPILEPSY DEVICES MARKET FOR DIET, BY TYPE, 2018–2027 (USD MILLION)

TABLE 134 EASTERN EUROPE: EPILEPSY DEVICES MARKET, BY TECHNOLOGY, 2018–2027 (USD MILLION)

TABLE 135 EASTERN EUROPE: EPILEPSY DEVICES MARKET FOR DEEP BRAIN STIMULATION, BY TYPE 2018–2027 (USD MILLION)

TABLE 136 EASTERN EUROPE: EPILEPSY DEVICES MARKET, BY SEZIURE DETECTION AND PREDICTION DEVICES, 2018–2027 (USD MILLION)

TABLE 137 EASTERN EUROPE: EPILEPSY DEVICES MARKET, BY END USER, 2018–2027 (USD MILLION)

TABLE 138 ASIA-PACIFIC: EPILEPSY DEVICES MARKET, BY COUNTRY, 2018–2027 (USD MILLION)

TABLE 139 ASIA PACIFIC: EPILEPSY DEVICES MARKET, BY PRODUCT TYPE, 2018–2027 (USD MILLION)

TABLE 140 ASIA-PACIFIC: EPILEPSY DEVICES MARKET FOR WEARABLE DEVICES, BY TYPE, 2018–2027 (USD MILLION)

TABLE 141 ASIA-PACIFIC: EPILEPSY DEVICES MARKET FOR DIET, BY PRODUCT TYPE, 2018–2027 (USD MILLION)

TABLE 142 ASIA-PACIFIC: EPILEPSY DEVICES MARKET, BY TECHNOLOGY, 2018–2027 (USD MILLION)

TABLE 143 ASIA-PACIFIC: EPILEPSY DEVICES MARKET FOR DEEP BRAIN STIMULATION, BY TYPE, 2018–2027 (USD MILLION)

TABLE 144 ASIA-PACIFIC: EPILEPSY DEVICES MARKET, BY SEZIURE DETECTION AND PREDICTION DEVICES, 2018–2027 (USD MILLION)

TABLE 145 ASIA-PACIFIC: EPILEPSY DEVICES MARKET, BY END USER, 2018–2027 (USD MILLION)

TABLE 146 CHINA: EPILEPSY DEVICES MARKET, BY PRODUCT TYPE, 2018–2027 (USD MILLION)

TABLE 147 CHINA: EPILEPSY DEVICES MARKET FOR WEARABLE DEVICES, BY TYPE, 2018–2027 (USD MILLION)

TABLE 148 CHINA: EPILEPSY DEVICES MARKET FOR DIET, BY TYPE, 2018–2027 (USD MILLION)

TABLE 149 CHINA: EPILEPSY DEVICES MARKET, BY TECHNOLOGY, 2018–2027 (USD MILLION)

TABLE 150 CHINA: EPILEPSY DEVICES MARKET FOR DEEP BRAIN STIMULATION, BY TYPE, 2018–2027 (USD MILLION)

TABLE 151 CHINA: EPILEPSY DEVICES MARKET, BY SEZIURE DETECTION AND PREDICTION DEVICES, 2018–2027 (USD MILLION)

TABLE 152 CHINA: EPILEPSY DEVICES MARKET, BY END USER, 2018–2027 (USD MILLION)

TABLE 153 INDIA: EPILEPSY DEVICES MARKET, BY PRODUCT TYPE, 2018–2027 (USD MILLION)

TABLE 154 INDIA: EPILEPSY DEVICES MARKET FOR WEARABLE DEVICES, BY TYPE, 2018–2027 (USD MILLION)

TABLE 155 INDIA: EPILEPSY DEVICES MARKET FOR DIET, BY TYPE, 2018–2027 (USD MILLION)

TABLE 156 INDIA: EPILEPSY DEVICES MARKET, BY TECHNOLOGY, 2018–2027 (USD MILLION)

TABLE 157 INDIA: EPILEPSY DEVICES MARKET FOR DEEP BRAIN STIMULATION, BY TYPE 2018–2027 (USD MILLION)

TABLE 158 INDIA: EPILEPSY DEVICES MARKET, BY SEZIURE DETECTION AND PREDICTION DEVICES, 2018–2027 (USD MILLION)

TABLE 159 INDIA: EPILEPSY DEVICES MARKET, BY END USER, 2018–2027 (USD MILLION)

TABLE 160 JAPAN: EPILEPSY DEVICES MARKET, BY PRODUCT TYPE, 2018–2027 (USD MILLION)

TABLE 161 JAPAN: EPILEPSY DEVICES MARKET FOR WEARABLE DEVICES, BY TYPE, 2018–2027 (USD MILLION)

TABLE 162 JAPAN: EPILEPSY DEVICES MARKET FOR DIET, BY TYPE, 2018–2027 (USD MILLION)

TABLE 163 JAPAN: EPILEPSY DEVICES MARKET, BY TECHNOLOGY, 2018–2027 (USD MILLION)

TABLE 164 JAPAN: EPILEPSY DEVICES MARKET FOR DEEP BRAIN STIMULATION, BY TYPE 2018–2027 (USD MILLION)

TABLE 165 JAPAN: EPILEPSY DEVICES MARKET, BY SEZIURE DETECTION AND PREDICTION DEVICES, 2018–2027 (USD MILLION)

TABLE 166 JAPAN: EPILEPSY DEVICES MARKET, BY END USER, 2018–2027 (USD MILLION)

TABLE 167 SOUTH KOREA: EPILEPSY DEVICES MARKET, BY PRODUCT TYPE, 2018–2027 (USD MILLION)

TABLE 168 SOUTH KOREA: EPILEPSY DEVICES MARKET FOR WEARABLE DEVICES, BY TYPE, 2018–2027 (USD MILLION)

TABLE 169 SOUTH KOREA: EPILEPSY DEVICES MARKET FOR DIET, BY PRODUCT TYPE, 2018–2027 (USD MILLION)

TABLE 170 SOUTH KOREA: EPILEPSY DEVICES MARKET, BY TECHNOLOGY, 2018–2027 (USD MILLION)

TABLE 171 SOUTH KOREA: EPILEPSY DEVICES MARKET FOR DEEP BRAIN STIMULATION, BY TECHNOLOGY 2018–2027 (USD MILLION)

TABLE 172 SOUTH KOREA: EPILEPSY DEVICES MARKET, BY SEZIURE DETECTION AND PREDICTION DEVICES, 2018–2027 (USD MILLION)

TABLE 173 SOUTH KOREA: EPILEPSY DEVICES MARKET, BY END USER, 2018–2027 (USD MILLION)

TABLE 174 AUSTRALIA: EPILEPSY DEVICES MARKET, BY PRODUCT TYPE, 2018–2027 (USD MILLION)

TABLE 175 AUSTRALIA: EPILEPSY DEVICES MARKET FOR WEARABLE DEVICES, BY PRODUCT TYPE, 2018–2027 (USD MILLION)

TABLE 176 AUSTRALIA: EPILEPSY DEVICES MARKET FOR DIET, BY PRODUCT TYPE, 2018–2027 (USD MILLION)

TABLE 177 AUSTRALIA: EPILEPSY DEVICES MARKET, BY TECHNOLOGY, 2018–2027 (USD MILLION)

TABLE 178 AUSTRALIA: EPILEPSY DEVICES MARKET FOR DEEP BRAIN STIMULATION, BY TYPE 2018–2027 (USD MILLION)

TABLE 179 AUSTRALIA: EPILEPSY DEVICES MARKET, BY SEZIURE DETECTION AND PREDICTION DEVICES, 2018–2027 (USD MILLION)

TABLE 180 AUSTRALIA: EPILEPSY DEVICES MARKET, BY END USER, 2018–2027 (USD MILLION)

TABLE 181 REST OF ASIA PACIFIC: EPILEPSY DEVICES MARKET, BY PRODUCT TYPE, 2018–2027 (USD MILLION)

TABLE 182 REST OF ASIA PACIFIC: EPILEPSY DEVICES MARKET FOR WEARABLE DEVICES, BY PRODUCT TYPE, 2018–2027 (USD MILLION)

TABLE 183 REST OF ASIA PACIFIC: EPILEPSY DEVICES MARKET FOR DIET, BY TYPE, 2018–2027 (USD MILLION)

TABLE 184 REST OF ASIA PACIFIC: EPILEPSY DEVICES MARKET, BY TECHNOLOGY, 2018–2027 (USD MILLION)

TABLE 185 REST OF ASIA PACIFIC: EPILEPSY DEVICES MARKET FOR DEEP BRAIN STIMULATION, BY TYPE 2018–2027 (USD MILLION)

TABLE 186 REST OF ASIA PACIFIC: EPILEPSY DEVICES MARKET, BY SEZIURE DETECTION AND PREDICTION DEVICES, 2018–2027 (USD MILLION)

TABLE 187 REST OF ASIA PACIFIC: EPILEPSY DEVICES MARKET, BY END USER, 2018–2027 (USD MILLION)

TABLE 188 MIDDLE EAST & AFRICA: EPILEPSY DEVICES MARKET, BY REGION, 2018–2027 (USD MILLION)

TABLE 189 MIDDLE EAST & AFRICA: EPILEPSY DEVICES MARKET, BY PRODUCT TYPE, 2018–2027 (USD MILLION)

TABLE 190 MIDDLE EAST & AFRICA: EPILEPSY DEVICES MARKET FOR WEARABLE DEVICES, BY TYPE, 2018–2027 (USD MILLION)

TABLE 191 MIDDLE EAST & AFRICA: EPILEPSY DEVICES MARKET FOR DIET, BY TYPE, 2018–2027 (USD MILLION)

TABLE 192 MIDDLE EAST & AFRICA: EPILEPSY DEVICES MARKET, BY TECHNOLOGY, 2018–2027 (USD MILLION)

TABLE 193 MIDDLE EAST & AFRICA: EPILEPSY DEVICES MARKET FOR DEEP BRAIN STIMULATION, BY TYPE 2018–2027 (USD MILLION)

TABLE 194 MIDDLE EAST & AFRICA: EPILEPSY DEVICES MARKET, BY SEZIURE DETECTION AND PREDICTION DEVICES, 2018–2027 (USD MILLION)

TABLE 195 MIDDLE EAST & AFRICA: EPILEPSY DEVICES MARKET, BY END USER, 2018–2027 (USD MILLION)

TABLE 196 MIDDLE EAST: EPILEPSY DEVICES MARKET, BY PRODUCT TYPE, 2018–2027 (USD MILLION)

TABLE 197 MIDDLE EAST: EPILEPSY DEVICES MARKET FOR WEARABLE DEVICES, BY PRODUCT TYPE, 2018–2027 (USD MILLION)

TABLE 198 MIDDLE EAST: EPILEPSY DEVICES MARKET FOR DIET, BY TYPE, 2018–2027 (USD MILLION)

TABLE 199 MIDDLE EAST: EPILEPSY DEVICES MARKET, BY TECHNOLOGY, 2018–2027 (USD MILLION)

TABLE 200 MIDDLE EAST: EPILEPSY DEVICES MARKET FOR DEEP BRAIN STIMULATION, BY TYPE, 2018–2027 (USD MILLION)

TABLE 201 MIDDLE EAST: EPILEPSY DEVICES MARKET, BY SEZIURE DETECTION AND PREDICTION DEVICES, 2018–2027 (USD MILLION)

TABLE 202 MIDDLE EAST: EPILEPSY DEVICES MARKET, BY END USER, 2018–2027 (USD MILLION)

TABLE 203 AFRICA: EPILEPSY DEVICES MARKET, BY PRODUCT TYPE, 2018–2027 (USD MILLION)

TABLE 204 AFRICA: EPILEPSY DEVICES MARKET FOR WEARABLE DEVICES, BY TYPE, 2018–2027 (USD MILLION)

TABLE 205 AFRICA: EPILEPSY DEVICES MARKET FOR DIET, BY TYPE, 2018–2027 (USD MILLION)

TABLE 206 AFRICA: EPILEPSY DEVICES MARKET, BY TECHNOLOGY, 2018–2027 (USD MILLION)

TABLE 207 AFRICA: EPILEPSY DEVICES MARKET FOR DEEP BRAIN STIMULATION, BY TECHNOLOGY 2018–2027 (USD MILLION)

TABLE 208 AFRICA: EPILEPSY DEVICES MARKET, BY SEZIURE DETECTION AND PREDICTION DEVICES, 2018–2027 (USD MILLION)

TABLE 209 AFRICA: EPILEPSY DEVICES MARKET, BY END USER, 2018–2027 (USD MILLION)

TABLE 210 MAJOR PLAYERS IN THE GLOBAL EPILEPSY DEVICES MARKET

TABLE 211 MOST ACTIVE PLAYER IN THE GLOBAL EPILEPSY DEVICES MARKET

TABLE 212 PRODUC T LAUNCH/PRODUCT APPROVAL

TABLE 213 PARTNERSHIP/AGREEMENT

TABLE 214 COLLABORATION

TABLE 215 LIVANOVA PLC: PRODUCTS/SERVICES OFFERED

TABLE 216 LIVANOVA PLC: KEY DEVELOPMENTS

TABLE 217 MEDTRONIC PLC: PRODUCTS/SERVICES OFFERED

TABLE 218 MEDTRONIC PLC: KEY DEVELOPMENTS

TABLE 219 MEDPAGE LTD.: PRODUCTS/SERVICES OFFERED

TABLE 220 KONINKLIJKE PHILIPS NV: PRODUCTS/SERVICES OFFERED

TABLE 221 KONINKLIJKE PHILIPS NV: KEY DEVELOPMENTS

TABLE 222 COMPUMEIDCS LIMITED: PRODUCTS/SERVICES OFFERED

TABLE 223 NATUS MEDICAL INCORPORATED: PRODUCTS/SERVICES OFFERED

TABLE 224 NATUS MEDICAL INCORPORATED: KEY DEVELOPMENTS

TABLE 225 NIHON KOHDEN CORPORATION: PRODUCTS/SERVICES OFFERED

TABLE 226 MC10: PRODUCTS/SERVICES OFFERED

TABLE 227 EMPATICA INC: PRODUCTS/SERVICES OFFERED

TABLE 228 EMPATICA INC: KEY DEVELOPMENTS

TABLE 229 NEUROPACE INC: PRODUCTS/SERVICES OFFERED

TABLE 230 NEUROPACE INC: KEY DEVELOPMENTS

TABLE 231 BOSTON SCIENTIFIC CORPORATION: PRODUCTS/SERVICES OFFERED

TABLE 232 BOSTON SCIENTIFIC CORPORATION: KEY DEVELOPMENTS


LIST OF FIGURES

FIGURE 1 MARKET SYNOPSIS

FIGURE 2 GLOBAL EPILEPSY DEVICES MARKET STRUCTURE

FIGURE 3 BOTTOM-UP AND TOP-DOWN APPROACHES

FIGURE 4 MARKET DYNAMICS: EPILEPSY DEVICES MARKET

FIGURE 5 DRIVER IMPACT ANALYSIS

FIGURE 6 RESTRAINT IMPACT ANALYSIS

FIGURE 7 VALUE CHAIN ANALYSIS: GLOBAL EPILEPSY DEVICES MARKET

FIGURE 8 PORTER'S FIVE FORCES ANALYSIS: EPILEPSY DEVICES MARKET

FIGURE 9 GLOBAL EPILEPSY DEVICES MARKET, BY PRODUCT TYPE, 2020 & 2027 (USD MILLION)

FIGURE 10 GLOBAL: EPILEPSY DEVICES MARKET, BY TECHNOLOGY, 2020 & 2027 (USD MILLION)

FIGURE 11 GLOBAL: EPILEPSY DEVICES MARKET, BY SEIZURE DETECTION AND PREDICTION DEVICES, 2020 & 2027 (USD MILLION)

FIGURE 12 GLOBAL EPILEPSY DEVICES MARKET, BY END USER, 2020 & 2027 (USD MILLION)

FIGURE 13 GLOBAL: EPILEPSY DEVICES MARKET, BY REGION 2020 & 2027 (USD MILLION)

FIGURE 14 GLOBAL: EPILEPSY DEVICES MARKET SHARE (%), BY REGION, 2020

FIGURE 15 AMERICAS: EPILEPSY DEVICES MARKET SHARE (%), BY REGION, 2020

FIGURE 16 NORTH AMERICA: EPILEPSY DEVICES MARKET SHARE (%), BY COUNTRY, 2020

FIGURE 17 EUROPE: EPILEPSY DEVICES MARKET SHARE (%), BY REGION, 2020

FIGURE 18 WESTERN EUROPE: EPILEPSY DEVICES MARKET SHARE (%), BY COUNTRY, 2020

FIGURE 19 ASIA PACIFIC: EPILEPSY DEVICES MARKET SHARE (%), BY COUNTRY, 2020

FIGURE 20 MIDDLE EAST & AFRICA: EPILEPSY DEVICES MARKET SHARE (%), BY REGION, 2020

FIGURE 21 BENCHMARKING OF MAJOR COMPETITORS

FIGURE 22 MAJOR STRATEGY ADOPTED BY KEY PLAYERS IN THE GLOBAL EPILEPSY DEVICES MARKET

FIGURE 23 GLOBAL EPILEPSY DEVICES MARKET: COMPETITIVE LANDSCAPE

FIGURE 24 SALES (USD MILLION), 2020

FIGURE 25 R&D EXPENDITURE (USD MILLION), 2020

FIGURE 26 LIVANOVA PLC: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 27 LIVANOVA PLC: SWOT ANALYSIS

FIGURE 28 MEDTRONIC PLC: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 29 MEDTRONIC PLC: SWOT ANALYSIS

FIGURE 30 MEDPAGE LTD.: SWOT ANALYSIS

FIGURE 31 KONINKLIJKE PHILIPS NV: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 32 KONINKLIJKE PHILIPS NV: SWOT ANALYSIS

FIGURE 33 COMPUMEDICS LIMITED: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 34 COMPUMEDICS: SWOT ANALYSIS

FIGURE 35 NATUS MEDICAL INCORPORATED: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 36 NATUS MEDICAL INCORPORATED: SWOT ANALYSIS

FIGURE 37 NIHON KOHDEN CORPORATION: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 38 NIHON KOHDEN CORPORATION: SWOT ANALYSIS

FIGURE 39 MC10: SWOT ANALYSIS

FIGURE 40 EMPATICA INC: SWOT ANALYSIS

FIGURE 41 NEUROPACE INC: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 42 NEUROPACE INC: SWOT ANALYSIS

FIGURE 43 BOSTON SCIENTIFIC CORPORATION: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 44 BOSTON SCIENTIFIC CORPORATION: SWOT ANALYSIS

てんかんデバイス市場

世界のてんかん装置市場は、2027年までに2,648.73万米ドルを超え、年平均成長率 9.02% に達すると予想されています。

セグメンテーション

製品タイプ別 Conventional Devices Wearable Devices Implantable Devices Diet
テクノロジー別 Vagus Nerve Stimulation Deep Brain Stimulation Accelerometery Responsive Neurostimulation
エンドユーザー別 Hospitals And Clinics Neurology Centers Home Care Settings

キープレーヤー

  • LivaNova PLC (UK)
  • Medtronic (Ireland)
  • Medpage Ltd (England)
  • Koninklijke Philips N.V. (Netherlands)
  • Compumedics Limited (Australia)
  • Natus Medical Incorporated (US)
  • Nihon Kohden Corporation (Japan)
  • MC10 (US)
  • Emp

運転手

  • Growing prevalence of epilepsy amongst geriatric population
  • Increasing cases of brain injuries due to road accidents
Speak to Analyst Request a Free Sample

てんかん装置の市場予測


世界のてんかん装置市場は、2027年までに2,648.73万米ドルを超え、年平均成長率 9.02% に達すると予想されています。


市場の概要:


てんかん装置は、てんかん状態の発作を特定できる電子機器です。てんかん装置の需要は、世界中で前年に比べて増加しています。増加する神経障害は、世界のてんかん装置市場の主要な推進力として機能しています。しかし、発展途上国におけるてんかん装置の一般の認識と利用可能性の欠如は、予測期間中の世界的なてんかん装置市場の成長を妨げています。市場の主要プレーヤーによる既存の製品ポートフォリオを拡大するための合併や買収などの戦略的提携は、世界のてんかんデバイス市場に機会を創出することが期待されています。


COVID-19分析:


COVID-19のパンデミックは、世界中のいくつかの市場に悪影響を及ぼし、てんかん装置の需要にも影響を与えました。いくつかの研究では、患者の8〜35%が発作の増加を経験しており、てんかん装置の需要が高まっていることが示されました。しかし、世界中の政府は、市場の需要を妨げているロックダウンなどの制限を課しています。いくつかの政府機関は、選択的脳波診断手順を一時停止していました。たとえば、イタリア神経生理学会、イタリアてんかん防止連盟、イタリア神経生理学協会、国際臨床神経生理学連盟がそのような規制を通過しました。病気の診断は、政府の規制と、ウイルスに感染する患者の恐怖のために妨げられてきました。ウェイン州立大学によると、2021年1月、49か国の212人の小児神経科医を対象とした調査では、脳波の手順が90%減少しました。しかし、世界中で規制が緩和されるにつれて、てんかん装置の需要は再び増加し、全体的に。Covid-19の影響は短期的なもののようです。


市場動態:


マーケットドライバー


  • 高齢者の間でのてんかんの有病率の増加


研究によると、高齢者はてんかんに罹患するリスクが高いことが示されています。米国国立慢性疾患予防・健康増進センターによると、脳卒中やアルツハイマー病などの神経障害の副作用、転倒による頭部外傷のリスクの増加、脳腫瘍など、高齢者はてんかんのリスクが高くなっています。2020年8月の米国疾病管理予防センター(CDC)による別の報告では、米国で約300万人がてんかんを患っています。そのうち100万人が55歳以上です。したがって、高齢者のてんかんの有病率の増加が市場の成長を牽引しています。



  • 交通事故による脳損傷の症例が増えている


市場制約


  • 発展途上国におけるてんかん装置に対する国民の認識と利用可能性の欠如


てんかんは、脳に影響を与える慢性疾患であり、あらゆる年齢の人々に起こり得る。2019年6月のWHOによると、世界中で5000万人以上の人々が影響を受けています。彼らはさらに、てんかんの影響を受けた人々のほぼ80%が低中所得国に属していると述べました。このような郡に住むてんかん患者の約4分の3は、てんかんに対する必要な診断、モニタリング、および治療を受けていない。残念ながら、これらの低中所得国の多くは適切な医療インフラにアクセスできないため、潜在的なエンドユーザーであった可能性のある人々の大部分がてんかんデバイスにアクセスできないため、市場の成長を妨げています。市場。


市場機会


  • てんかんデバイスの新興市場


アジア太平洋地域などの新興市場は、将来市場を牽引すると予想されます。世界保健機関(WHO)によると、2019年6月現在、てんかん患者の80%以上が低中所得国に住んでいます。さらに、オーストラリアのロイヤルメルボルン病院によると、アジアの約2300万人がてんかんを患っており、これは世界のてんかん有病率のほぼ半分を占めています。


世界のてんかん装置の市場シェア (%)、製品タイプ別、2020

出典:MRFR 分析


バリューチェーン分析/技術分析/規制への影響


世界のてんかんデバイス市場は着実に成長しており、近い将来も同じ速度で成長し続けると予想されています。これは、製品を一般に公開するための既存のプレーヤーの貢献が高まり、てんかん障害の有病率が高まっているためです。てんかんデバイス市場のサプライチェーン分析は、5つの主要な要素で構成されています。研究と製品開発、それに続く製品の製造、流通、販売、および販売後のサービスです。


セグメントの概要


世界のてんかん装置市場は、製品タイプ、技術、発作検出および予測装置、および流通チャネルに基づいて分割されています。


製品タイプ別



  • 従来型デバイス


従来のデバイスとは、患者の継続的なモニタリングに使用される脳波(EEG)デバイスを指します。WHOによると、適切な病因文書と異常な脳波パターンが発作再発の最も正確な予測である。したがって、てんかん患者を監視するためのEEGデバイスに対する大きな需要があります。



  • ウェアラブルデバイス


ウェアラブルデバイスセグメントは、時計、ブレスレット、カメラデバイス、マットレスデバイス、窒息防止枕などにさらに分岐しています。発作の症状は人によって異なる場合があります。発作を直ちに止める方法はありませんが、ウェアラブルてんかんデバイス技術の急速な進歩は、近年、かなりの人気を得ています。



  • 埋め込み型デバイス


現在、患者の大多数は植込み型装置で治療されています。迷走神経刺激(VNS)、深部脳刺激(DBS)、および応答性神経刺激(RNS)は、FDAによって承認された3種類の神経調節療法であり、埋め込み型てんかん装置を使用して達成されます。



  • 国会


食事療法は、主に発作薬との併用療法で行われます。医師と栄養士は、特定の患者の発作の管理に役立つ高脂肪、低炭水化物の食事である従来のケトン食を処方および監督します。


テクノロジー別


技術に基づいて、市場は迷走神経刺激(VNS)、応答性神経刺激(RNS)、深部脳刺激(DBS)、および加速度測定に分けられます。



  • 迷走神経刺激


迷走神経刺激(VNS)は、難治性てんかんまたは薬剤耐性てんかんの成人および小児に対するFDA承認の治療法です。これは、穏やかな電気パルスを迷走神経を介して脳に送る神経調節法です。



  • 脳深部刺激


ディープブレインスティミュレーション(DBS)は、薬が患者にとって効果を失ったときに使用され、脳の関与する領域に送られる電気刺激の助けを借りて、脳の働きを調整するように設計されていますてんかん。



  • 加速度計


Report Attribute/Metric Details   Market Size   2027: USD 2,648.73 Million   CAGR   9.02%   Base Year   2020   Forecast Period   2021-2027   Historical Data   2018 & 2019   Forecast Units   Value (USD Million)   Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends   Segments Covered   Product Type, Technology, Seizure Detection and Prediction Devices End User, and Region   Geographies Covered   Americas, Europe, Asia-Pacific, and Middle East and Africa   Key Vendors   • LivaNova PLC (UK), • Medtronic (Ireland) • Medpage Ltd (England) • Koninklijke Philips N.V. (Netherlands) • Compumedics Limited (Australia) • Natus Medical Incorporated (US) • Nihon Kohden Corporation (Japan) • MC10 (US) • Empatica Inc (US) • NeuroPace, Inc (US) • Boston Scientific Corporation (US)   Key Market Opportunities   • Emerging markets for epilepsy devices   Key Market Drivers   • Growing prevalence of epilepsy amongst geriatric population • Increasing cases of brain injuries due to road accidents

Speak to Analyst Ask for Customization